How to Stop an LSD Trip: Harm Reduction Strategies

Once LSD is absorbed and active in your brain, there is no reliable way to instantly end the experience. The drug binds tightly to serotonin receptors and holds on for hours, which is a core reason trips last as long as they do. What you can do is reduce the intensity, manage distress, and in some cases use medications that significantly shorten the experience. The strategies below range from things anyone can do in the moment to pharmacological interventions used in clinical and emergency settings.

Why LSD Trips Last So Long

A big part of understanding how to manage an LSD trip is understanding why it persists. LSD binds to serotonin receptors in a way that is structurally unusual. Researchers who solved the crystal structure of LSD bound to one of its key brain targets found that the drug essentially gets trapped inside the receptor, with a portion of the receptor folding over the molecule like a lid. This explains why LSD produces effects that are longer and more potent than those of closely related compounds, even at very small doses.

¹

In controlled studies comparing LSD to other psychedelics, the subjective effects of LSD lasted roughly eight and a half hours on average when no intervention was given. That is longer than psilocybin, though shorter than mescaline. The onset of LSD effects is fairly rapid, and the time to peak tends to be more consistent between people compared to other psychedelics.

²

This long duration matters for harm reduction because it means a person in distress may be looking at many more hours of intense experience. It also means that any strategy, whether psychological or pharmacological, needs to account for a long timeline rather than a quick fix.

Grounding Techniques and Psychological Support

The first line of defense during a difficult LSD experience is environmental and psychological. This is the approach used by experienced harm reduction practitioners, crisis volunteers at festivals, and increasingly in clinical psychedelic research settings. The core idea is to reduce stimulation and help the person reconnect with a sense of safety.

Practically, this means:

• Change the setting: Move to a quieter, dimmer space. Loud music, crowds, and bright or chaotic environments can amplify distress. A calm room with soft lighting can make a measurable difference in how someone feels.
• Offer calm reassurance: Remind the person that they took a drug, that the effects are temporary, and that they are physically safe. This sounds obvious, but during intense psychedelic states, people can lose track of these basic facts.
• Use grounding exercises: Ask the person to focus on physical sensations like the feeling of their feet on the floor, to breathe slowly, or to describe objects in the room. These simple techniques help redirect attention away from spiraling thoughts.
• Avoid arguing with the experience: Trying to convince someone that what they are perceiving is not real rarely works and can increase panic. Acknowledging their experience without reinforcing frightening interpretations is more effective.

A qualitative study of practitioners who support people through difficult psychedelic experiences found that the most frequently recommended strategies included grounding and mindfulness techniques, peer and community support, and meaning-making after the experience. For extended difficulties, individual psychotherapy with trauma-informed approaches was also commonly recommended.

³

The Value of a Trip Sitter

Having a sober, trusted person present is one of the most discussed harm reduction practices in psychedelic communities, and the research broadly supports it. In a study investigating the relationship between harm reduction practices and psychedelic outcomes, participants who had trusted friends present during their experiences gave the practice high harm reduction scores. Interestingly, having a specifically designated unintoxicated trip sitter was less commonly practiced but was recognized as especially important for first-time users. One participant described a “really bad experience” that they said could have been avoided by having a sober sitter and a safe space.

⁴

The trip sitter’s job is not to direct the experience or provide therapy. It is to be a stable, calm presence who can help with practical things: getting water, changing the music, offering a blanket, and gently redirecting if someone becomes agitated or confused. If the situation deteriorates beyond what grounding can handle, the sitter is the person who can make the call to seek medical help. For experienced users tripping in familiar settings, the sitter role can be informal. For anyone using LSD for the first time or taking a higher dose than usual, having someone sober and trustworthy is hard to overstate.

Pharmacological Options for Ending or Reducing a Trip

Sometimes psychological support is not enough, and medication becomes the best option. The two main pharmacological approaches are benzodiazepines and serotonin receptor blockers. They work differently and have different goals.

Benzodiazepines

Benzodiazepines do not directly block the action of LSD at serotonin receptors. What they do is reduce anxiety, agitation, and panic, which are often the most distressing parts of a bad trip. In emergency settings, benzodiazepines like midazolam are considered first-line treatment for psychomotor agitation caused by LSD and similar substances.

⁵

In practice, a benzodiazepine will not stop visual distortions or the perceptual effects of LSD. It will, however, take the edge off the fear and physical tension that makes a difficult trip feel unbearable. For many people, reducing anxiety is enough to shift the experience from terrifying to manageable. Some users keep a benzodiazepine on hand specifically for this purpose, though obtaining one typically requires a prescription. The sedative effect can also help someone sleep as the drug wears off, which is welcome after many hours of an unwanted experience.

Serotonin Receptor Blockers

If benzodiazepines are like turning down the emotional volume, serotonin antagonists are closer to actually flipping the switch. LSD produces its characteristic effects primarily by activating 5-HT2A serotonin receptors. A drug that blocks those receptors can directly counteract the trip itself, not just the anxiety around it.

The most studied agent for this purpose is ketanserin, a selective 5-HT2A antagonist. In a randomized, double-blind, placebo-controlled study in healthy volunteers, ketanserin reversed the acute response to LSD, cutting the duration of subjective effects from about eight and a half hours down to roughly three and a half hours. It also reversed LSD-induced alterations of mind, including visual and auditory changes and ego dissolution, and reduced adverse cardiovascular effects like elevated blood pressure and heart rate. Importantly, ketanserin did not change how LSD was processed in the body; it simply blocked the receptor where LSD was acting.

⁶

The catch is that ketanserin is not widely available outside of research and clinical settings. It is used as a blood pressure medication in some countries but is not a standard pharmacy item in the United States. A recent review of candidate “trip killer” medications evaluated serotonin antagonists, antipsychotics, and certain anxiety and depression drugs for their potential as abortive agents. The authors noted that binding strength at the molecular level, the ability to functionally block receptor effects, and a lack of side effects are the key considerations when choosing an agent.

⁷

Antipsychotic medications like haloperidol or olanzapine also block 5-HT2A receptors and have been used in emergency departments for severe psychedelic crises. However, older antipsychotics in particular can have unpleasant side effects and may paradoxically worsen the subjective experience in some cases. This is an area where clinical judgment matters and self-medication is risky. In emergency departments, the Swiss practical guide for acute recreational drug intoxication recommends benzodiazepines as first-line, with serotonin-specific interventions reserved for confirmed serotonin syndrome.

⁵

When to Call for Emergency Help

Most difficult LSD experiences, while deeply unpleasant, are not medical emergencies. But some are. Knowing where that line falls is important for trip sitters and anyone nearby.

An analysis of LSD-related incidents that led to emergency medical treatment found that psychological and physiological symptoms tended to cluster separately. Anxiety, panic, and confusion grouped together as one pattern. A different cluster involved palpitations, chest pain, and difficulty breathing, often alongside physical accident or trauma.

⁸

Call emergency services if you observe any of the following:

• Chest pain or difficulty breathing: These can indicate a cardiovascular problem, especially if the person has an underlying heart condition or if the substance was not actually LSD.
• Seizures: Real LSD at normal doses very rarely causes seizures. Seizure activity could suggest a different, more dangerous substance was consumed.
• Dangerously high body temperature: Hyperthermia, especially with rigid muscles and altered consciousness, may indicate serotonin syndrome or stimulant toxicity.
• Risk of self-harm: If the person is expressing suicidal thoughts, attempting to hurt themselves, or behaving in ways that put them in physical danger, this is a psychiatric emergency regardless of the substance involved.
• Loss of consciousness: LSD does not typically cause people to pass out. Unresponsiveness suggests a different substance or a medical complication.

Emergency clinicians managing these situations follow a protocol that includes keeping the patient in a quiet, low-stimulation environment, benzodiazepine sedation as a first step, temperature monitoring, IV fluids, and avoiding serotonergic anti-nausea drugs. Severe cases may require intensive care with active cooling and respiratory support.

⁵

Test Before You Take Anything

A significant number of bad outcomes attributed to “LSD” actually involve other substances sold as LSD. The most dangerous imposters are NBOMe compounds, synthetic phenethylamines with strong hallucinogenic properties that can be laid on blotter paper to look identical to LSD tabs. Unlike LSD, NBOMe compounds have been responsible for severe poisonings and deaths. They produce effects that overlap with LSD but also cause tachycardia, hypertension, and seizures at rates that LSD does not.

⁹

One practical clue: LSD is tasteless on blotter paper, while NBOMe compounds tend to have a bitter, numbing, metallic taste. This is not a reliable safety test on its own, but a markedly bitter tab is a red flag. The more reliable approach is chemical testing.

Reagent test kits, available legally and inexpensively online, can identify whether a substance is consistent with LSD or likely something else. A survey of electronic music festival attendees in Colorado found that about three-quarters had used reagent test kits at some point, and roughly half reported testing their drugs always or most of the time before consuming them. Among those who tested, the vast majority had never consumed a substance that tested differently than expected.

¹⁰

Testing is arguably the single most effective harm reduction step you can take before the trip even begins. Many “how do I stop this trip” emergencies could be avoided entirely by confirming the substance is actually LSD and not something far more dangerous.

Legal Protections When Calling for Help

Fear of arrest is one of the biggest reasons people hesitate to call emergency services during a drug crisis. Good Samaritan Laws, which exist in most U.S. states and in several other countries, are designed to address this by offering legal protections to people who seek emergency help for themselves or someone else during an overdose or drug-related medical event.

The strength of these protections varies significantly. A large U.S. study found that Good Samaritan Laws providing protection from arrest, when combined with naloxone access laws, were associated with a reduction in overdose deaths of about 7% two years after enactment. Laws that only protected against prosecution or offered mitigation at sentencing showed no significant association with reduced mortality.

¹¹

While most Good Samaritan Laws were written with opioid overdoses in mind, many apply more broadly to drug-related medical emergencies. Check your state or country’s specific law. The practical takeaway: if someone is in medical danger during an LSD experience, especially if you suspect they may have taken a different substance, calling for help is almost always the right decision. Emergency responders and emergency department staff are focused on stabilizing the patient, not on pressing charges.

Persistent Effects After the Trip Ends

For most people, LSD’s effects resolve completely within a day. But a small subset of users experience lingering perceptual disturbances that can persist for weeks, months, or longer. This is known as hallucinogen persisting perception disorder, or HPPD, and it tends to involve visual phenomena like trailing images, halos around objects, or patterns appearing in peripheral vision when they are not there.

HPPD comes in two recognized forms. The first is brief, benign flashbacks that resolve on their own. The second is more persistent and distressing, often linked to negative mood states. Anxiety and depressive features can worsen episodes, and anticipatory anxiety about the visual disturbances can itself become a significant source of impairment, leading to avoidant behavior that restricts normal functioning.

¹²

Treatment for HPPD remains limited and not well studied. Some evidence suggests that high-potency benzodiazepines like clonazepam may help. In a study of 16 patients with LSD-induced HPPD and anxiety features, clonazepam at 2 mg per day for two months produced significant relief. The improvement persisted through a six-month follow-up period after the medication was stopped. The researchers suggested that clonazepam’s serotonergic properties might make it more effective than other benzodiazepines for this specific condition.

¹³

If you or someone you know is experiencing persistent visual disturbances or significant anxiety after LSD use, seeking help from a mental health professional is important. HPPD is a recognized condition with treatment options, but it is poorly understood by many general practitioners. Cannabis and stimulants are anecdotally reported to worsen HPPD symptoms, and some practitioners recommend complete abstinence from all psychoactive substances during recovery.

Dose, Set, and Setting Still Matter Most

Most of the harm reduction conversation around LSD focuses on what to do when things go wrong. But the evidence consistently points to prevention as the most powerful tool. Taking a known substance at a known dose, in a comfortable environment, with people you trust, and in a stable emotional state dramatically reduces the likelihood of a crisis in the first place. “Set and setting” is not just a slogan from the 1960s; it remains the framework that clinical psychedelic researchers use to minimize adverse reactions in controlled trials.

If you are considering LSD and want to reduce risk, the practical hierarchy looks like this: test your substance, start with a low dose, choose your environment carefully, have a trusted person nearby, and know in advance what your pharmacological backup plan is if things go sideways. None of these eliminate risk entirely. Psychedelics are unpredictable, and even experienced users occasionally have difficult experiences. But the difference between a difficult experience and a dangerous one often comes down to preparation and the quality of support available in the moment.